Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Peifer

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Nature Communications|December 18, 2025
Lack of caspase 8 directs neuronal progenitor-like reprogramming and small cell lung cancer progressionAriadne Androulidaki, Fanyu Liu, Christina M Bebber, et al.
Blood|February 4, 2021
Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1Vivien Kohlhaas, Stuart James Blakemore, Mona Al-Maarri, et al.
Nature Genetics|November 22, 2016
Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijackingJoachim Weischenfeldt, Taronish Dubash, Alexandros P Drainas, et al.
The Journal of Clinical Investigation|August 22, 2023
Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancerFlorian Malchers, Lucia Nogova, Martijn Ha van Attekum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2024
<i>TERT</i> Expression and Clinical Outcome in Pulmonary CarcinoidsLisa Werr, Christoph Bartenhagen, Carolina Rosswog, et al.
Science Translational Medicine|June 16, 2017
Drugging the catalytically inactive state of RET kinase in RET-rearranged tumorsDennis Plenker, Maximilian Riedel, Johannes Brägelmann, et al.
Blood Cancer Discovery|November 8, 2022
Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention StrategiesRuth Flümann, Julia Hansen, Benedikt W Pelzer, et al.
Cancer Discovery|February 28, 2018
Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived XenograftsBenjamin J Drapkin, Julie George, Camilla L Christensen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2016
Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR InhibitorsSandra Ortiz-Cuaran, Matthias Scheffler, Dennis Plenker, et al.
Blood Cancer Discovery|January 15, 2021
An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular VulnerabilitiesRuth Flümann, Tim Rehkämper, Pascal Nieper, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Nature Communications|December 18, 2025
Lack of caspase 8 directs neuronal progenitor-like reprogramming and small cell lung cancer progressionAriadne Androulidaki, Fanyu Liu, Christina M Bebber, et al.
Blood|February 4, 2021
Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1Vivien Kohlhaas, Stuart James Blakemore, Mona Al-Maarri, et al.
Nature Genetics|November 22, 2016
Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijackingJoachim Weischenfeldt, Taronish Dubash, Alexandros P Drainas, et al.
The Journal of Clinical Investigation|August 22, 2023
Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancerFlorian Malchers, Lucia Nogova, Martijn Ha van Attekum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2024
<i>TERT</i> Expression and Clinical Outcome in Pulmonary CarcinoidsLisa Werr, Christoph Bartenhagen, Carolina Rosswog, et al.
Science Translational Medicine|June 16, 2017
Drugging the catalytically inactive state of RET kinase in RET-rearranged tumorsDennis Plenker, Maximilian Riedel, Johannes Brägelmann, et al.
Blood Cancer Discovery|November 8, 2022
Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention StrategiesRuth Flümann, Julia Hansen, Benedikt W Pelzer, et al.
Cancer Discovery|February 28, 2018
Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived XenograftsBenjamin J Drapkin, Julie George, Camilla L Christensen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2016
Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR InhibitorsSandra Ortiz-Cuaran, Matthias Scheffler, Dennis Plenker, et al.
Blood Cancer Discovery|January 15, 2021
An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular VulnerabilitiesRuth Flümann, Tim Rehkämper, Pascal Nieper, et al.
Pageof 11